Vor Biopharma Inc. Common Stock (VOR) is a publicly traded Healthcare sector company. As of May 21, 2026, VOR trades at $15.35 with a market cap of $765.65M and a P/E ratio of -0.21. VOR moved +10.12% today. Year to date, VOR is +46.98%; over the trailing twelve months it is +335.57%. Its 52-week range spans $2.62 to $65.80. Analyst consensus is strong buy with an average price target of $33.80. Rallies surfaces VOR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Recent VOR insider activity includes RA CAPITAL MANAGEMENT, L.P. sold 165.15K, RA CAPITAL MANAGEMENT, L.P. sold 171.96K, RA CAPITAL MANAGEMENT, L.P. sold 458.41K, RA CAPITAL MANAGEMENT, L.P. sold 53.64K, and RA CAPITAL MANAGEMENT, L.P. sold 153.74K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
| Metric | Value |
|---|---|
| Price | $15.35 |
| Market Cap | $765.65M |
| P/E Ratio | -0.21 |
| EPS | $-70.50 |
| Dividend Yield | 0.00% |
| 52-Week High | $65.80 |
| 52-Week Low | $2.62 |
| Volume | 930 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-695.98M |
| Gross Margin | 0.00% |
6 analysts cover VOR: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $33.80.